Docosahexaenoic Acid and Bronchopulmonary Dysplasia in Preterm Infants.

Author
:
CT Collins
M Makrides
AJ McPhee
TR Sullivan
PG Davis
M Thio
K Simmer
VS Rajadurai
J Travadi
MJ Berry
HG Liley
GF Opie
K Tan
K Lui
SA Morris
J Stack
MJ Stark
MC Chua
PA Jayagobi
J Holberton
S Bolisetty
IR Callander
DL Harris
RA Gibson
Abstract
:

Studies in animals and in humans have suggested that docosahexaenoic acid (DHA), an n-3 long-chain polyunsaturated fatty acid, might reduce the risk of bronchopulmonary dysplasia, but appropriately designed trials are lacking.
Year of Publication
:
2017
Journal
:
The New England journal of medicine
Volume
:
376
Issue
:
13
Number of Pages
:
1245-1255
Date Published
:
2017
ISSN Number
:
0028-4793
URL
:
https://www.nejm.org/doi/10.1056/NEJMoa1611942?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww.ncbi.nlm.nih.gov
DOI
:
10.1056/NEJMoa1611942
Short Title
:
N Engl J Med
Download citation